We serve Chemical Name:1-[2-(1H-indol-3-yl)ethyl]-2,5-dimethylpyrrole-3-carbaldehyde CAS:119636-71-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![1-[2-(1H-indol-3-yl)ethyl]-2,5-dimethylpyrrole-3-carbaldehyde](https://a.dearchem.com/CAS2/119636-71-4.png)
Chemical Name:1-[2-(1H-indol-3-yl)ethyl]-2,5-dimethylpyrrole-3-carbaldehyde
CAS.NO:119636-71-4
Synonyms:1-(2-(Indol-3-yl)-ethyl)-2,5-dimethyl-pyrrole-3-aldehyde;1-[2-(1H-Indol-3-yl)-ethyl]-2,5-dimethyl-1H-pyrrole-3-carbaldehyde
Molecular Formula:C17H18N2O
Molecular Weight:266.33800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.79000
Exact Mass:266.14200
LogP:3.64140
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(2-(Indol-3-yl)-ethyl)-2,5-dimethyl-pyrrole-3-aldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[2-(1H-Indol-3-yl)-ethyl]-2,5-dimethyl-1H-pyrrole-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-(Indol-3-yl)-ethyl)-2,5-dimethyl-pyrrole-3-aldehyde Use and application,1-[2-(1H-Indol-3-yl)-ethyl]-2,5-dimethyl-1H-pyrrole-3-carbaldehyde technical grade,usp/ep/jp grade.
Related News: For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. 2,3-dihydroperoxy-7-(4,5,6-trihydroperoxy-13,24,33,44,54,64-hexaoxin-2-yl)-13,24,34,43,54,73,104-hexaoxino[3,2]hexaoxane manufacturers The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. 8-(4-((L-leucyl)oxy)piperidin-1-yl)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid hydrochloride suppliers For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. 5-benzyl-3-oxo-2,3-dihydro-benzo[b]oxepine-7-carboxylic acid methyl ester vendor & factory As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base.,The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core.
